Risk communication AC meeting
This article was originally published in The Tan Sheet
FDA will hold a public meeting of the Risk Communication Advisory Committee on Feb. 28 and 29 at the Washington, D.C. North/Gaithersburg, Md. Hilton, the agency announces in a Feb. 8 Federal Register notice. The committee will meet the first day from 8 a.m. to 5 p.m. for presentations and discussion of the relation of the agency's risk communication programs and FDA's responsibilities. The committee will continue on the second day from 8 a.m. to 4 p.m. with presentations and discussion of FDA's proposed template for product recall press releases, the agency says...
You may also be interested in...
The Daiichi Sankyo affiliate successfully argued that Novartis willfully infringed two patents covering its discoveries in the BRAF inhibitor drug class, getting nearly $178m in damages and future royalties.
Adverum said it would cease developing ADVM-022 for DME and focus on wet AMD, but the adverse events that prompted the shift could invite further scrutiny in an already competitive market.
Abbott expects the ongoing recovery of medical procedure volumes to continue even as new virus variants are causing COVID-19 cases to increase in some geographies.